Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells

Artibani M., Masuda K., Hu Z., Rauher PC., Mallett G., Wietek N., Morotti M., Chong K., KaramiNejadRanjbar M., Zois CE., Dhar S., El-Sahhar S., Campo L., Blagden SP., Damato S., Pathiraja PN., Nicum S., Gleeson F., Laios A., Alsaadi A., Santana Gonzalez L., Motohara T., Albukhari A., Lu Z., Bast Jr. RC., Harris AL., Ejsing CS., Klemm RW., Yau C., Sauka-Spengler T., Ahmed AA.

DOI

10.1172/jci.insight.147929

Type

Journal article

Journal

JCI Insight

Publisher

American Society for Clinical Investigation

Publication Date

04/05/2021

Permalink Original publication